Pantoprazole Sodium 40mg Delayed-Release Tablets from Canada
These are oral delayed-release tablets containing 40mg of pantoprazole sodium, a proton pump inhibitor used to treat gastroesophageal reflux disease (GERD) and erosive esophagitis. They fall under HTS 3004.90.92.55 as unmixed medicaments put up in measured doses for retail sale, primarily affecting the digestive system via pantoprazole or its salts.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Verify pantoprazole content via certificate of analysis to confirm classification under 3004.90.92.55; mislabeling risks reclassification
• Ensure FDA registration and NDC labeling for retail packs; provide stability data for delayed-release formulations
• Avoid bulk shipments without measured doses, as they may shift to unmixed chemical headings like 2933